Study Summary
This triallooks at how a drug affects people with a blood disorder called polycythemia vera, to assess safety and effectiveness.
- Polycythemia Vera
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
2 Primary · 0 Secondary · Reporting Duration: 24 weeks
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
3 Treatment Groups
Ropeginterferon alfa-2b-njft
1 of 3
P1101 250-350-500mcg
1 of 3
Ropeginterferon alfa-2b-njft (P1101)
1 of 3
Active Control
Experimental Treatment
100 Total Participants · 3 Treatment Groups
Primary Treatment: P1101 250-350-500mcg · No Placebo Group · Phase 3
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| Michigan | 66.7% |
| California | 33.3% |
What site did they apply to?
| University of Michigan | 50.0% |
| University of Utah | 50.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
How many prior treatments have patients received?
| 3+ | 100.0% |
Why did patients apply to this trial?
- "On Jakafi and still require routine phlebotomies, always tired an no energy because of borderline anemic."
Frequently Asked Questions
Are we still enrolling people in this clinical trial?
"This particular clinical trial, as indicated by the website clinicaltrials.gov is not currently looking for new patients to enroll. Although this study is no longer active, there are 56 other trials that may be of interest and are still recruiting individuals." - Anonymous Online Contributor
What kind of side effects does Ropeginterferon alfa-2b-njft (P1101) have?
"There is some existing data to suggest the efficacy of Ropeginterferon alfa-2b-njft (P1101), which, combined with its multiple rounds of safety testing, gives it a score of 3." - Anonymous Online Contributor
Are other hospitals in our state conducting this research as well?
"There are a total of 16 clinical trial sites currently running this study. The locations closest to major metropolitan areas include Toronto, Bronx, and Vancouver. If you enroll in the study, it is best to choose the location that is most convenient for you to minimize travel demands." - Anonymous Online Contributor